362 related articles for article (PubMed ID: 11924752)
1. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Agodoa LY
Clin Nephrol; 2002 Mar; 57(3):208-14. PubMed ID: 11924752
[TBL] [Abstract][Full Text] [Related]
2. Polycystic kidney disease in patients on the renal transplant waiting list: trends in hematocrit and survival.
Abbott KC; Agodoa LY
BMC Nephrol; 2002 Aug; 3():7. PubMed ID: 12194700
[TBL] [Abstract][Full Text] [Related]
3. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study.
Yao X; Lei W; Shi N; Lin W; Du X; Zhang P; Chen J
BMC Nephrol; 2020 Jul; 21(1):310. PubMed ID: 32727426
[TBL] [Abstract][Full Text] [Related]
4. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
[TBL] [Abstract][Full Text] [Related]
5. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for pulmonary embolism in chronic dialysis patients.
Tveit DP; Hshieh P; Cruess D; Agodoa LY; Welch PG; Abbott KC
J Nephrol; 2002; 15(3):241-7. PubMed ID: 12113594
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Agodoa LY
Clin Nephrol; 2001 Sep; 56(3):207-10. PubMed ID: 11597035
[TBL] [Abstract][Full Text] [Related]
8. Patient characteristics and outcomes by GN subtype in ESRD.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
[TBL] [Abstract][Full Text] [Related]
9. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.
Perrone RD; Ruthazer R; Terrin NC
Am J Kidney Dis; 2001 Oct; 38(4):777-84. PubMed ID: 11576881
[TBL] [Abstract][Full Text] [Related]
10. Mortality risk in patients with autosomal dominant polycystic kidney disease.
Mladsi D; Zhou X; Mader G; Sanon M; Wang J; Barnett C; Willey C; Seliger S
BMC Nephrol; 2024 Feb; 25(1):56. PubMed ID: 38365638
[TBL] [Abstract][Full Text] [Related]
11. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
12. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States.
Stack AG; Molony DA; Rahman NS; Dosekun A; Murthy B
Kidney Int; 2003 Sep; 64(3):1071-9. PubMed ID: 12911559
[TBL] [Abstract][Full Text] [Related]
13. Lower Incidence of End-Stage Renal Disease but Suboptimal Pre-Dialysis Renal Care in Schizophrenia: A 14-Year Nationwide Cohort Study.
Hsu YH; Cheng JS; Ouyang WC; Lin CL; Huang CT; Hsu CC
PLoS One; 2015; 10(10):e0140510. PubMed ID: 26469976
[TBL] [Abstract][Full Text] [Related]
14. A comparison of transplant outcomes in peritoneal and hemodialysis patients.
Snyder JJ; Kasiske BL; Gilbertson DT; Collins AJ
Kidney Int; 2002 Oct; 62(4):1423-30. PubMed ID: 12234315
[TBL] [Abstract][Full Text] [Related]
15. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States.
Stack AG; Murthy BV; Molony DA
Kidney Int; 2004 Jun; 65(6):2398-408. PubMed ID: 15149353
[TBL] [Abstract][Full Text] [Related]
16. Etiology of bacterial septicemia in chronic dialysis patients in the United States.
Abbott KC; Agodoa LY
Clin Nephrol; 2001 Aug; 56(2):124-31. PubMed ID: 11522089
[TBL] [Abstract][Full Text] [Related]
17. Quality Improvement Targets for Regional Variation in Surgical End-Stage Renal Disease Care.
Zarkowsky DS; Hicks CW; Arhuidese I; Canner JK; Obeid T; Qazi U; Schneider E; Abularrage CJ; Black JH; Freischlag JA; Malas MB
JAMA Surg; 2015 Aug; 150(8):764-70. PubMed ID: 26107005
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Hypolite IO; Agodoa LY
Clin Nephrol; 2002 Jul; 58(1):9-15. PubMed ID: 12141416
[TBL] [Abstract][Full Text] [Related]
19. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
20. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
Batista PB; Lopes AA; Costa FA
Ren Fail; 2005; 27(6):651-6. PubMed ID: 16350813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
